Replies to post #97078 on Biotech Values

[jb_118]

MNTA

While we're marginally on the subject of MNTA commenting on TEVA approvals, was there anything mentioned at the meeting relative to lovenox on either TEVA's chances of approval or substitutibility of either the MNTA or TEVA version?